A New Approach to Treating Alzheimer's Disease Receives Major NIA Backing


T3D Therapeutics to Receive $9 Million Multiyear National Institute on Aging Grant for Phase 2 PIONEER Study in Mild-to-Moderate Alzheimer's Disease Patients RESEARCH ... Lees verder

Bron: ANP Pers support
Tags:
Geplaatst: 20 mei 2019 - 06:02